Amneal Announces U.S. FDA Filing Acceptance of Abbreviated New Drug Application for Naloxone Hydrochloride Nasal Spray, USP, 4mg
Go back to Amneal Announces U.S. FDA Filing Acceptance of Abbreviated New Drug Application for Naloxone Hydrochloride Nasal Spray, USP, 4mg| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 16.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.11 | 52 Week High | $0.19 | |||
| Open | $16.11 | 52 Week Low | $0.07 | |||
| Day High | $16.11 | P/E | N/A | |||
| Day Low | $16.11 | EPS | $-0.01 | |||
| Volume | 132 | |||||
